Transforming ATMPs from Concept to Reality
At CCRM Nordic, we offer a wide range of services for ATMPs, spanning from business creation and strategic advice to early-stage development and clinical manufacturing. The aim? To make more advanced therapies reach market and benefit patients.
Company and Product Development
Company and Product Development
Creating a successful medicinal product depends as much on refining the production processes and control strategy as it does on building a resilient and long-term business strategy. Our experienced team provides the support and expertise needed to achieve that.
Analytics and Process Development
Analytics and Process Development
We specialize in analytical and process development for cell and gene therapies, guiding the crucial transition from research towards commercial production and scalable processes. Our interim laboratory is where ideas take shape.
Upcoming GMP Facility: Excellence in Manufacturing
Upcoming GMP Facility: Excellence in Manufacturing
Our upcoming state-of-the-art GMP facility is dedicated to advancing ATMP projects from concept to reality, ensuring the highest standards of quality and safety.
How can we assist you?
Your Research, Fast-Tracked
Our services are developed to benefit early-stage researchers aiming to transform their research into commercial, scalable therapies. Researchers can either get support for specific tasks or take part in a larger, tailored, program. Currently, CCRM Nordic provides consultation, process development facilities and CMC expertise. New additions to our service offering are added continuously.
Our Facilities – Today and Tomorrow
State of the Art GMP and Process Development Facilities
CCRM Nordic is establishing state of the art facilities at the Life Science cluster GoCo Health Innovation City in Mölndal, south of Gothenburg. The new specially designed facilities for process development and GMP manufacturing will be under construction and preparation for commissioning during 2024 – 2026. In the meantime, interim offices and process development laboratories will be available in the GoCo House. The establishment will take place in stages:
Phase I (2023 – 2025)
- Establish the organization and the CCRM Nordic service offering.
- Build competence and capabilities along the whole value chain.
- Establish interim offices and process development laboratory (up and running in Q2 2024) in GoCo House.
- Preparations and building of the new facilities, Phase II.
Phase II (2026 -)
- Move into purpose-built, state-of-the-art facilities in the GoCo Lab.
- 2000 m2 of GMP manufacturing clean rooms and laboratories.
- 1000 m2 process development laboratories.
- Expand business and technology platforms.
“Our ATMP manufacturing, logistics and clinical trial infrastructure have been built up and authorized in two EU-countries since these services couldn´t been sourced in Sweden. My estimation is that three times as many persons could have been engaged in Sweden compared to the current situation, should Sweden been able to efficiently provide such ATMP-services when our project took off.“
Petter Björquist
CEO, VERIGRAFT AB
How We Aim to Benefit Society
CCRM Nordic offers state-of-the-art, cost-efficient support to ATMP developers. We are an important part of Sweden’s emerging ATMP ecosystem, striving to position Sweden as a leader in ATMP development by 2030. The infrastructure’s full-scale operation is expected to have a significant long-term impact on that target.
- Faster and more cost-efficient translation of ATMP projects, both commercial and academic, to clinical phase of development.
- Formation of new ATMPs and technologies.
- Accelerating sector growth; jobs and export income through industrialization.
- Increased competitiveness and growth possibilities for ATMP developers.
- Making Sweden more attractive for ATMP development, clinical trials and investments.